Literature DB >> 23098657

Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats.

M Snorek1, D Hodyc, V Sedivý, J Durišová, A Skoumalová, J Wilhelm, J Neckář, F Kolář, J Herget.   

Abstract

The effect of three-day fasting on cardiac ischemic tolerance was investigated in adult male Wistar rats. Anesthetized open-chest animals (pentobarbitone 60 mg/kg, i.p.) were subjected to 20-min left anterior descending coronary artery occlusion and 3-h reperfusion for infarct size determination. Ventricular arrhythmias were monitored during ischemia and at the beginning (3 min) of reperfusion. Myocardial concentrations of beta-hydroxybutyrate and acetoacetate were measured to assess mitochondrial redox state. Short-term fasting limited the infarct size (48.5+/-3.3 % of the area at risk) compared to controls (74.3+/-2.2 %) and reduced the total number of premature ventricular complexes (12.5+/-5.8) compared to controls (194.9+/-21.9) as well as the duration of ventricular tachycardia (0.6+/-0.4 s vs. 18.8+/-2.5 s) occurring at early reperfusion. Additionally, fasting increased the concentration of beta-hydroxybutyrate and beta-hydroxybutyrate/acetoacetate ratio (87.8+/-27.0) compared to controls (7.9+/-1.7), reflecting altered mitochondrial redox state. It is concluded that three-day fasting effectively protected rat hearts against major endpoints of acute I/R injury. Further studies are needed to find out whether these beneficial effects can be linked to altered mitochondrial redox state resulting from increased ketogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098657     DOI: 10.33549/physiolres.932338

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  22 in total

Review 1.  HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury.

Authors:  Min Xie; Yida Tang; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2019-02-27       Impact factor: 5.000

Review 2.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

3.  Metabolic Strategies in Healthcare: A New Era.

Authors:  Matthew Cl Phillips
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 4.  β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations.

Authors:  Shao Wei; Liu Binbin; Wu Yuan; Zhang Zhong; Lin Donghai; Huang Caihua
Journal:  Front Mol Biosci       Date:  2022-06-13

5.  Impact of high-fat, low-carbohydrate diet on myocardial substrate oxidation, insulin sensitivity, and cardiac function after ischemia-reperfusion.

Authors:  Jian Liu; Peipei Wang; Samuel L Douglas; Joshua M Tate; Simon Sham; Steven G Lloyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 6.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

7.  The role of point-of-care 3-hydroxybutyrate testing in patients with type 2 diabetes undergoing coronary angiography.

Authors:  S Vigili de Kreutzenberg; A Avogaro
Journal:  J Endocrinol Invest       Date:  2017-02-11       Impact factor: 4.256

Review 8.  Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

Authors:  Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick
Journal:  Cardiovasc Diabetol       Date:  2017-12-04       Impact factor: 9.951

Review 9.  Cardiac metabolism as a driver and therapeutic target of myocardial infarction.

Authors:  Coert J Zuurbier; Luc Bertrand; Christoph R Beauloye; Ioanna Andreadou; Marisol Ruiz-Meana; Nichlas R Jespersen; Duvaraka Kula-Alwar; Hiran A Prag; Hans Eric Botker; Maija Dambrova; Christophe Montessuit; Tuuli Kaambre; Edgars Liepinsh; Paul S Brookes; Thomas Krieg
Journal:  J Cell Mol Med       Date:  2020-05-08       Impact factor: 5.310

Review 10.  Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  Front Physiol       Date:  2014-07-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.